Healthcare provider profile · identity verified

Andrew Schweitzer, MD

Family Practice · BOISE, ID · NPI 1538549068

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	191	50
Atorvastatin Calcium	Atorvastatin Calcium	151	49
Amlodipine Besylate	Amlodipine Besylate	105	29
Levothyroxine Sodium	Levothyroxine Sodium	105	33
Duloxetine Hcl	Duloxetine Hcl	101	30
Gabapentin	Gabapentin	96	29
Furosemide	Furosemide	93	27
Tamsulosin Hcl	Tamsulosin Hcl	93	23
Potassium Chloride	Potassium Chloride	90	29
Eliquis	Apixaban	84	17
Tramadol Hcl	Tramadol Hcl	82	18
Losartan Potassium	Losartan Potassium	77	28
Metoprolol Succinate	Metoprolol Succinate	75	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	71	15
Allopurinol	Allopurinol	56	13
Hydrochlorothiazide	Hydrochlorothiazide	56	13
Pantoprazole Sodium	Pantoprazole Sodium	55	17
Omeprazole	Omeprazole	54	20
Meloxicam	Meloxicam	52	15
Montelukast Sodium	Montelukast Sodium	51	18
Metformin Hcl	Metformin Hcl	47	18
Albuterol Sulfate Hfa	Albuterol Sulfate	44	17
Chlorthalidone	Chlorthalidone	44	12
Trazodone Hcl	Trazodone Hcl	43	12
Simvastatin	Simvastatin	41	14
Famotidine	Famotidine	40	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	suppressed
Prednisone	Prednisone	38	16
Ventolin Hfa	Albuterol Sulfate	38	suppressed
Jardiance	Empagliflozin	37	suppressed
Fluticasone Propionate	Fluticasone Propionate	36	suppressed
Metformin Hcl Er	Metformin Hcl	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	33	suppressed
Alendronate Sodium	Alendronate Sodium	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	suppressed
Sertraline Hcl	Sertraline Hcl	32	suppressed
Finasteride	Finasteride	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Xarelto	Rivaroxaban	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Paliperidone Er	Paliperidone	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Spironolactone	Spironolactone	21	suppressed
Topiramate	Topiramate	21	suppressed
Tresiba Flextouch U-100	Insulin Degludec	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	17
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Sucralfate	Sucralfate	18	suppressed
Atenolol	Atenolol	17	suppressed
Estradiol	Estradiol	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Cephalexin	Cephalexin	14	12
Lorazepam	Lorazepam	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Azithromycin	Azithromycin	12	11
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error